Agents typically used are trimethoprim, TMPSMX
, or nitrofurantoin (31,32) (table 4 (31)), none of which demonstrated superiority in a Cochrane review.
bethesdensis CRO/GEN/VAN, Recovered CRO/DOX/TMPSMX
* AMK, amikacin; CAZ, ceftazidime; CFD, cefdinir; CGD, chronic granulomatous disease; CLI, clindamycin; CLR, clarithromycin; CIP, ciprofloxacin; CPD, cefpodoxime; CRO, ceftriaxone; CSP, caspofungin; CYBB, cytochrome b-245, [beta] polypeptide; DOX, doxycycline; GEN, gentamicin; HSCT, hematopoietic stem cell transplant; IFN-[gamma], interferon-[gamma]; INH, isoniazid; ITZ, itraconazole; LAMB, liposomal amphotericin B; LVX, levofloxacin; LZD, linezolid; MEM, meropenem; MTZ, metronidazole; NCF2, neutrophil cytosolic factor 2; RFB, rifabutin; RIF, rifampin; TEC, teicoplanin; TGC, tigecycline; TMPSMX
, trimethoprim/sulfamethoxazole; TOB, tobramycin; VAN, vancomycin; VRZ, voriconazole.
medical institutions that submit such information to an electronic database, 39% were resistant to ampicillin, 18% were resistant to TMPSMX
, and 2% were resistant to ciprofloxacin, reported Dr.